✦ LIBER ✦

First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study

✍ Scribed by Ulrich Gatzemeier; Joachim von Pawel; Ihor Vynnychenko; Petr Zatloukal; Filippo de Marinis; Wilfried EE Eberhardt; Luis Paz-Ares; Karl-Maria Schumacher; Thomas Goddemeier; Kenneth J O'Byrne; Robert Pirker

Book ID: 117785530
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 220 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(10)70278-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR expression as a predictor of surviv

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

✍ Robert Pirker; Jose R Pereira; Joachim von Pawel; Maciej Krzakowski; Rodryg Raml 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 872 KB

A phase II study of carboplatin and pacl

A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC)

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

First line chemotherapy with gemcitabine

First line chemotherapy with gemcitabine in advanced non-small cell lung cancer elderly patients: a randomized phase II study of 3-week versus 4-week schedule

✍ Quoix, Elisabeth; Breton, Jean-Luc; Ducoloné, Alain; Mennecier, Bertrand; Depier 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Prospective phase II trial of a combinat

Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer

✍ Baek, Jin Ho; Kim, Hawk; Ahn, Jong-Joon; Jegal, Yangjin; Seo, Kwang Won; Ra, Seu 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 258 KB

P-207 Docetaxel and irinotecan as first

P-207 Docetaxel and irinotecan as first line chemotherapy in patients with unresectable locally advanced or metastatic non small cell lung cancer (NSCLC): A phase II study

✍ Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Comparison of pemetrexed plus cisplatin

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials

✍ Treat, Joseph; Scagliotti, Giorgio V.; Peng, Guangbin; Monberg, Matthew J.; Obas 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 783 KB